Stock Scorecard
Stock Summary for GSK Plc (GSK) - $50.23 as of 5/19/2026 6:09:10 PM EST
Total Score
10 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GSK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GSK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GSK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GSK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GSK (45 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for GSK
Financial Details for GSK
Company Overview |
|
|---|---|
| Ticker | GSK |
| Company Name | GSK Plc |
| Country | N/A |
| Description | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 50.23 |
| Price 4 Years Ago | 30.66 |
| Last Day Price Updated | 5/19/2026 6:09:10 PM EST |
| Last Day Volume | 3,108,116 |
| Average Daily Volume | 4,074,161 |
| 52-Week High | 61.21 |
| 52-Week Low | 34.48 |
| Last Price to 52 Week Low | 45.68% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 31.04 |
| Sector PE | 100.89 |
| 5-Year Average PE | 15.80 |
| Free Cash Flow Ratio | 22.23 |
| Industry Free Cash Flow Ratio | 43.86 |
| Sector Free Cash Flow Ratio | 29.78 |
| Current Ratio Most Recent Quarter | 0.79 |
| Total Cash Per Share | 2.26 |
| Book Value Per Share Most Recent Quarter | 11.08 |
| Price to Book Ratio | 4.17 |
| Industry Price to Book Ratio | 14.47 |
| Sector Price to Book Ratio | 19.73 |
| Price to Sales Ratio Twelve Trailing Months | 3.05 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.33 |
| Sector Price to Sales Ratio Twelve Trailing Months | 23.86 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 2,007,512,000 |
| Market Capitalization | 100,837,327,760 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 5/15/2026 |
| Previous Dividend Amount | 0.4776 |
| Current Dividend Amount | 0.4611 |
| Total Years Dividend Increasing | 2 |
| Trailing Annual Dividend Rate | 1.80 |
| Trailing Annual Dividend Yield | 3.53% |
| Forward Annual Dividend Rate | 1.84 |
| Forward Annual Dividend Yield | 3.62% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 3.53% |
| 5-Year Average Dividend Yield | 4.69% |
| 1-Year Dividend Growth Rate Percentage | 8.14% |
| 3-Year Dividend Growth Rate Percentage | 3.99% |
| 5-Year Dividend Growth Rate Percentage | -0.68% |
| All-Time Dividend Growth Rate Percentage | 0.71% |
| Dividend Payout Ratio | 46.44% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 8.40% |
| Annual Earnings Growth | 121.98% |
| Reported EPS 12 Trailing Months | 3.88 |
| Reported EPS Past Year | 1.26 |
| Reported EPS Prior Year | 4.59 |
| Net Income Twelve Trailing Months | 5,829,000,000 |
| Net Income Past Year | 5,716,000,000 |
| Net Income Prior Year | 2,575,000,000 |
| Quarterly Revenue Growth YOY | 1.50% |
| 5-Year Revenue Growth | 6.05% |
| Operating Margin Twelve Trailing Months | 36.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 4,538,965,000 |
| Total Cash Past Year | 3,391,029,000 |
| Total Cash Prior Year | 3,693,000,000 |
| Net Cash Position Most Recent Quarter | -10,169,035,000 |
| Net Cash Position Past Year | -10,623,971,000 |
| Long Term Debt Past Year | 14,015,000,000 |
| Long Term Debt Prior Year | 13,703,000,000 |
| Total Debt Most Recent Quarter | 14,708,000,000 |
| Equity to Debt Ratio Past Year | 0.54 |
| Equity to Debt Ratio Most Recent Quarter | 0.62 |
| Total Stockholder Equity Past Year | 16,348,214,000 |
| Total Stockholder Equity Prior Year | 13,671,000,000 |
| Total Stockholder Equity Most Recent Quarter | 23,541,432,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 6,236,295,705 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.11 |
| Free Cash Flow Past Year | 5,824,498,769 |
| Free Cash Flow Prior Year | 3,572,000,000 |
Options |
|
| Put/Call Ratio | 0.28 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.33 |
| MACD Signal | -0.70 |
| 20-Day Bollinger Lower Band | 45.84 |
| 20-Day Bollinger Middle Band | 53.80 |
| 20-Day Bollinger Upper Band | 61.75 |
| Beta | 0.30 |
| RSI | 36.11 |
| 50-Day SMA | 46.12 |
| 150-Day SMA | 39.03 |
| 200-Day SMA | 37.05 |
System |
|
| Modified | 5/19/2026 12:14:10 AM EST |